THE INFLUENCE OF PHARMACOTHERAPY WITH BETA BLOCKERS AND CALCIUM CHANNEL BLOCKERS ON CARDIOVASCULAR RISK IN PATIENTS WITH STABLE ANGINA

Stable angina is a major cause of chronic morbidity and mortality worldwide. Besides a rational pharmacotherapy of disease requires a strict control of factorsdeterminants of risk and incidence of coronary heart disease. The present study is performed between 2010 - 2011, on a number of 161 patients with stable angina, with beta-blockers and/or calcium channel blockers in treatment. Risk stratification process is the next step after a diagnosis of stable angina patients framing involves a risk class, with the final aim to define optimal treatment options and determining prognosis. Score prediction grid offers 10 years of cardiovascular mortality and consider five risk factors: sex, age, smoking status, total cholesterol, systolic blood pressure.This data was calculated statistically and presented in results and discussion. After 12 months of treatment, in the context of changing living conditions improve lipid profile and blood pressure, most patients had moderate cardiovascular risk.